Boehringer Wins UPC Appeal To Block Generic Fibrosis Drug
German Pharmaceuticals giant Boehringer Ingelheim has persuaded a Unified Patent Court appeals panel to stop Portuguese rival Zentiva from selling a generic version of its fibrosis drug, proving there is an...To view the full article, register now.
Already a subscriber? Click here to view full article